{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:31:54Z","timestamp":1777624314120,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100005205","name":"Janssen Research & Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck","doi-asserted-by":"publisher","award":["ESCITALDEP4001"],"award-info":[{"award-number":["ESCITALDEP4001"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","award":["CHN2007CNS001"],"award-info":[{"award-number":["CHN2007CNS001"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007132","name":"Otsuka","doi-asserted-by":"publisher","award":["ARI-IIT-02"],"award-info":[{"award-number":["ARI-IIT-02"]}],"id":[{"id":"10.13039\/501100007132","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.psychres.2019.02.036","type":"journal-article","created":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T02:03:14Z","timestamp":1550455394000},"page":"301-305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Association between symptom control and functional improvement in patients with acute schizophrenia: A post hoc analysis of an open-label, single-arm, multi-center study of paliperidone-extended release formulation"],"prefix":"10.1016","volume":"274","author":[{"given":"Tian Mei","family":"Si","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi long","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian Min","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shangli","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.psychres.2019.02.036_bib0001","first-page":"18","article-title":"Premorbid functioning, cognitive functioning, symptoms and outcome in schizophrenia","volume":"18","author":"Addington","year":"1993","journal-title":"J. Psychiatry Neurosci."},{"issue":", 06","key":"10.1016\/j.psychres.2019.02.036_bib0002","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1192\/bjp.157.6.853","article-title":"The Social Functioning Scale. The development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients","volume":"157","author":"Birchwood","year":"1990","journal-title":"Br. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2019.02.036_bib0003","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1192\/bjp.bp.110.078022","article-title":"Sleep-wake cycles and cognitive functioning in schizophrenia","volume":"198","author":"Bromundt","year":"2011","journal-title":"Br. J. Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.psychres.2019.02.036_bib0004","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.psychres.2004.10.007","article-title":"Emotion recognition, 'theory of mind,' and social behavior in schizophrenia","volume":"133","author":"Brune","year":"2005","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2019.02.036_bib0005","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2147\/NDT.S49263","article-title":"Current approaches to treatments for schizophrenia spectrum disorders, part II: psychosocial interventions and patient-focused perspectives in psychiatric care","volume":"9","author":"Chien","year":"2013","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"2","key":"10.1016\/j.psychres.2019.02.036_bib0006","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1017\/S0033291710000802","article-title":"The relationship of social function to depressive and negative symptoms in individuals at clinical high risk for psychosis","volume":"41","author":"Corcoran","year":"2011","journal-title":"Psychol. Med."},{"issue":"1\u20132","key":"10.1016\/j.psychres.2019.02.036_bib0007","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.psychres.2008.10.037","article-title":"Excessive daytime sleepiness in psychiatric disorders: prevalence, correlates and clinical significance","volume":"175","author":"Hawley","year":"2010","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2019.02.036_bib0008","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-244X-5-13","article-title":"Quality of sleep in patients with schizophrenia is associated with quality of life and coping","volume":"5","author":"Hofstetter","year":"2005","journal-title":"BMC Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2019.02.036_bib0009","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0920-9964(99)00137-1","article-title":"Verbal fluency and psychiatric symptoms in geriatric schizophrenia","volume":"42","author":"Howanitz","year":"2000","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2019.02.036_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6904-12-1","article-title":"Effects of paliperidone extended release on the symptoms and functioning of schizophrenia","volume":"12","author":"Huang","year":"2012","journal-title":"BMC Clin. Pharmacol."},{"key":"10.1016\/j.psychres.2019.02.036_bib0011","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/1471-244X-14-197","article-title":"Correlation between the Personal and Social Performance scale (PSP) and the Positive and Negative Syndrome Scale (PANSS) in a Greek sample of patients with schizophrenia","volume":"14","author":"Jelastopulu","year":"2014","journal-title":"BMC Psychiatry"},{"issue":"6","key":"10.1016\/j.psychres.2019.02.036_bib0012","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/YCO.0b013e328314e144","article-title":"The new approach: psychosocial functioning as a necessary outcome criterion for therapeutic success in schizophrenia","volume":"21","author":"Juckel","year":"2008","journal-title":"Curr. Opin. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2019.02.036_bib0013","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"6","key":"10.1016\/j.psychres.2019.02.036_bib0014","first-page":"349","article-title":"Effectiveness, tolerability and safety of flexible-dose treatment with oral extended release paliperidone in acute schizophrenia","volume":"22","author":"Li","year":"2010","journal-title":"Shanghai Arch. Psychiatry"},{"key":"10.1016\/j.psychres.2019.02.036_bib0015","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2147\/NDT.S158353","article-title":"Factors related to improvement of symptoms, function, and caregiver burden in Chinese patients with schizophrenia after switching to paliperidone palmitate once-monthly from oral antipsychotics","volume":"14","author":"Li","year":"2018","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"6","key":"10.1016\/j.psychres.2019.02.036_bib0016","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/YIC.0000000000000092","article-title":"Efficacy and tolerability of paliperidone ER in patients with unsatisfactorily controlled schizophrenia by other antipsychotics: a flexible-dose approach","volume":"30","author":"Mauri","year":"2015","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.psychres.2019.02.036_bib0017","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/schbul\/sbn152","article-title":"A review of instruments for measuring functional recovery in those diagnosed with psychosis","volume":"35","author":"Mausbach","year":"2009","journal-title":"Schizophr. Bull."},{"issue":"Suppl 2","key":"10.1016\/j.psychres.2019.02.036_bib0018","first-page":"3","article-title":"Atypical antipsychotics: sleep, sedation, and efficacy","volume":"6","author":"Miller","year":"2004","journal-title":"Prim Care Companion J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2019.02.036_bib0019","first-page":"1511","article-title":"The social functional outcome of being naturalistically treated with paliperidone extended-release in patients with schizophrenia","volume":"11","author":"Nakagawa","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"3","key":"10.1016\/j.psychres.2019.02.036_bib0020","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1176\/appi.ps.56.3.273","article-title":"Defining and measuring clinical effectiveness in the treatment of schizophrenia","volume":"56","author":"Nasrallah","year":"2005","journal-title":"Psychiatr. Serv."},{"issue":"2","key":"10.1016\/j.psychres.2019.02.036_bib0021","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.clinthera.2010.02.003","article-title":"Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tablets","volume":"32","author":"Patrick","year":"2010","journal-title":"Clin. Ther."},{"issue":"2","key":"10.1016\/j.psychres.2019.02.036_bib0022","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1185\/03007990802611919","article-title":"Reliability, validity and ability to detect change of the clinician-rated Personal and Social Performance scale in patients with acute symptoms of schizophrenia","volume":"25","author":"Patrick","year":"2009","journal-title":"Curr. Med. Res. Opin."},{"issue":"1\u20132","key":"10.1016\/j.psychres.2019.02.036_bib0023","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0920-9964(01)00273-0","article-title":"The relationship between positive symptoms and instrumental work functioning in schizophrenia: a 10 year follow-up study","volume":"56","author":"Racenstein","year":"2002","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.psychres.2019.02.036_bib0024","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.psychres.2014.04.018","article-title":"Negative symptoms and everyday functioning in schizophrenia: a cross-sectional study in a real world-setting","volume":"218","author":"Rocca","year":"2014","journal-title":"Psychiatry Res."},{"issue":"3","key":"10.1016\/j.psychres.2019.02.036_bib0025","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0920-9964(01)00231-6","article-title":"Recovery from psychosis in schizophrenia and schizoaffective disorder: symptoms and neurocognitive rate-limiters for the development of social behavior skills","volume":"55","author":"Smith","year":"2002","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2019.02.036_bib0026","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.2147\/NDT.S88085","article-title":"Psychosocial functioning in schizophrenia: are some symptoms or demographic characteristics predictors across the functioning domains?","volume":"11","author":"Suttajit","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"6","key":"10.1016\/j.psychres.2019.02.036_bib0027","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3109\/08039488.2014.996252","article-title":"Effects of paliperidone extended release on functioning level and symptoms of patients with recent onset schizophrenia: an open-label, single-arm, flexible-dose, 12-months follow-up study","volume":"69","author":"Ucok","year":"2015","journal-title":"Nord. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2019.02.036_bib0028","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1521\/psyc.2009.72.4.370","article-title":"Longitudinal associations between negative symptoms and social functioning in schizophrenia: the moderating role of employment status and setting","volume":"72","author":"Weinberg","year":"2009","journal-title":"Psychiatry"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178118323102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178118323102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T13:44:09Z","timestamp":1565185449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178118323102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":28,"alternative-id":["S0165178118323102"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2019.02.036","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between symptom control and functional improvement in patients with acute schizophrenia: A post hoc analysis of an open-label, single-arm, multi-center study of paliperidone-extended release formulation","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2019.02.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}